On the Use of Herbal Medicines in Management of Inflammatory Bowel Diseases: A Systematic Review of Animal and Human Studies
- 10 July 2008
- journal article
- review article
- Published by Springer Nature in Digestive Diseases and Sciences
- Vol. 54 (3) , 471-480
- https://doi.org/10.1007/s10620-008-0368-x
Abstract
Because of potential adverse events and lack of effectiveness of standard therapies, the use of complementary and alternative medicines (CAM), particularly of herbal therapies, for inflammatory bowel disease (IBD) is increasing. Results from the use of herbal therapies for managing IBD are promising, and no serious adverse events have been reported from them. Herbal therapies show their benefit in managing IBD by different mechanisms such as immune system regulation, antioxidant activity, inhibition of leukotriene B4, inhibition of nuclear factor-kappa B (NF-κB), and antiplatelet activity. In this paper, all reported herbal therapies established in animal IBD models or used for managing human IBD are systematically reviewed and their possible mechanisms of action discussed. Conducting clinical trials with high quality and validity (randomized, double blinded, controlled, on a large number of patients) to obtain more conclusive results about the use of herbal therapies in IBD is recommended.Keywords
This publication has 85 references indexed in Scilit:
- Novel uses for anti‐platelet agents as anti‐inflammatory drugsBritish Journal of Pharmacology, 2007
- Use of herbal preparations in the treatment of oxidant-mediated inflammatory disordersComplementary Therapies in Medicine, 2007
- A Meta-Analysis of Antibiotic Therapy for Active Ulcerative ColitisDigestive Diseases and Sciences, 2007
- Efficacy of T2 in Active Crohn’s Disease: A Prospective Study ReportDigestive Diseases and Sciences, 2007
- In vivo treatment with the herbal phenylethanoid acteoside ameliorates intestinal inflammation in dextran sulphate sodium-induced colitisClinical and Experimental Immunology, 2007
- Protection from experimental colitis by theaflavin‐3,3′‐digallate correlates with inhibition of IKK and NF‐κB activationBritish Journal of Pharmacology, 2006
- Curcumin regulated shift from Th1 to Th2 in trinitrobenzene sulphonic acid-induced chronic colitisActa Pharmacologica Sinica, 2006
- Effects of Ginkgo biloba Extract on Inflammatory Mediators (SOD, MDA, TNF‐α, NF‐κBp65, IL‐6) in TNBS‐Induced Colitis in RatsMediators of Inflammation, 2006
- Curcumin, the major component of food flavour turmeric, reduces mucosal injury in trinitrobenzene sulphonic acid‐induced colitisBritish Journal of Pharmacology, 2003
- Benefits of Zataria multiflora Boiss in Experimental Model of Mouse Inflammatory Bowel DiseaseEvidence-Based Complementary and Alternative Medicine, 2000